138 related articles for article (PubMed ID: 20035412)
1. Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds.
Aoki M; Yorozu A; Dokiya T
Jpn J Radiol; 2009 Dec; 27(10):410-5. PubMed ID: 20035412
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
Aoki M; Yorozu A; Dokiya T
Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
[TBL] [Abstract][Full Text] [Related]
3. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
4. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
5. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
[TBL] [Abstract][Full Text] [Related]
6. Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.
Roshan D; Joyce K; Woulfe P; Gorakati PR; Stock R; Sullivan FJ
Brachytherapy; 2021; 20(4):873-882. PubMed ID: 33840634
[TBL] [Abstract][Full Text] [Related]
7. Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.
Stock RG; Stone NN; Lo YC; Malhado N; Kao J; DeWyngaert JK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):899-906. PubMed ID: 11020588
[TBL] [Abstract][Full Text] [Related]
8. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
[TBL] [Abstract][Full Text] [Related]
9. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
Potters L; Calugaru E; Jassal A; Presser J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
[TBL] [Abstract][Full Text] [Related]
12. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.
Potters L; Cao Y; Calugaru E; Torre T; Fearn P; Wang XH
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):605-14. PubMed ID: 11395226
[TBL] [Abstract][Full Text] [Related]
15. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
16. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT.
Tanaka O; Hayashi S; Kanematsu M; Matsuo M; Nakano M; Maeda S; Deguchi T; Hoshi H
Radiat Med; 2007 Jan; 25(1):22-6. PubMed ID: 17225049
[TBL] [Abstract][Full Text] [Related]
17. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer.
Grigo J; Karius A; Hanspach J; Mücke L; Laun FB; Huang Y; Strnad V; Fietkau R; Bert C; Putz F
Brachytherapy; 2024; 23(1):96-105. PubMed ID: 38008648
[TBL] [Abstract][Full Text] [Related]
18. Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.
Girum KB; Lalande A; Quivrin M; Bessières I; Pierrat N; Martin E; Cormier L; Petitfils A; Cosset JM; Créhange G
Brachytherapy; 2018; 17(6):866-873. PubMed ID: 30217431
[TBL] [Abstract][Full Text] [Related]
19. Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional database.
Allen Z; Merrick GS; Grimm P; Blasko J; Sylvester J; Butler W; Chaudry UU; Sitter M
Med Dosim; 2008; 33(3):206-14. PubMed ID: 18674685
[TBL] [Abstract][Full Text] [Related]
20. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
